Back to Search Start Over

Pralsetinib and Sequential MET Inhibitors to Overcome MET Amplification Resistance in a Patient With a RET Fusion Driven Lung Cancer – Case Report

Authors :
Pascal Wang
Lise Matton
Fatima Kebir
Khaldoun Kerrou
Antonin Dubois
Roger Lacave
Jacques Cadranel
Vincent Fallet
Source :
Clinical Lung Cancer. 23:e568-e572
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Details

ISSN :
15257304
Volume :
23
Database :
OpenAIRE
Journal :
Clinical Lung Cancer
Accession number :
edsair.doi...........61ce85335f39f47622baea3bbec77b7c
Full Text :
https://doi.org/10.1016/j.cllc.2022.08.010